Spyre Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2019
Total Assets: $83.2M
Liabilities Breakdown FY2019
Total Liabilities: $23.1M
Asset Breakdown
Total Assets: $83.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.3M | 23.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $2.4M | 2.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $61.5M | 74.0% |
Liabilities Breakdown
Total Liabilities: $23.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.2M | 13.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $19.9M | 86.3% |